Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Display Technology (CDT), a subsidiary of Sumitomo Chemical, is a pioneer in the development of polymer organic light-emitting diode (P-OLED) technology. While historically focused on the display and lighting industries, the company has established a significant presence in the healthcare sector through its "Light for Health" initiative. This program leverages CDT's expertise in flexible, thin-film organic electronics to develop wearable medical devices for applications such as photodynamic therapy (PDT) and light-based wound healing. Their technology enables conformable light sources that can be integrated into medical patches, providing a more patient-friendly and ambulatory alternative to traditional bulky clinical light systems. CDT continues to collaborate with academic and clinical partners to advance the use of organic electronics in dermatology and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Display Technology.